Latest News about MDMA/assisted therapy
Recent news which mentions MDMA/assisted therapy
Multidisciplinary Association For Psychedelic Studies Funds MDMA-Assisted Therapy Trial For PTSD
August 29, 2024
From Benzinga
Lykos Therapeutics Strategic Reorganization Following FDA's Decision Rejecting MDMA For PTSD Treatment
August 16, 2024
Tickers
NEWS
From Benzinga
From Benzinga
Five Out Of Six Studies On MDMA Show Positive Results, Yet FDA Approval Still Faces Hurdles
August 07, 2024
Tickers
NEWS
From Benzinga
Art Installation Near White House Urges FDA To Approve MDMA-Assisted Therapy For Veterans As Decision Time Looms
July 29, 2024
Tickers
NEWS
From Benzinga
From Benzinga
Atai Life Sciences Shows Positive Results In Phase 1 Clinical Study For PTSD Treatment
January 04, 2024
From Benzinga
Could MDMA Revolutionize PTSD Treatment? In Historic Move, FDA Considers New Drug Application
December 12, 2023
From Benzinga
Canadian Practitioners Can Now Enroll In MDMA-Assisted Psychotherapy Training Program
September 25, 2023
From Benzinga
Psychedelics Researchers & Industry Leaders Weigh In On Groundbreaking PTSD Treatment News
September 15, 2023
Tickers
NUMIF
From Benzinga
Treating PTSD With MDMA Therapy: New Results From MAPS Clinical Study, FDA Submission Next
September 14, 2023
From Benzinga
From Benzinga
MDMA Deals: Optimi Supplies Numinus-MAPS Program & PharmAla Exports To Australian University
June 20, 2023
From Benzinga
Numinus Partners With MAPS To Conduct Phase 1 MDMA Assisted Therapy Investigational Study
June 16, 2023
From Benzinga
Promising Milestone: FDA Approves California-Based Trial Assessing MDMA For Schizophrenia
June 12, 2023
Tickers
PMBHF
From Benzinga
From Benzinga
Two Psychedelics Companies Collaborate To Provide Clinical-Grade MDMA Capsules For Authorized Patients And Studies
April 11, 2023
Tickers
FLHLF
From Benzinga
From Benzinga
MDMA News: Exclusive Supply Deal With Awakn Life Sciences & Canadian Company Expands Psychedelics Production
March 02, 2023
Tickers
AWKNF
From Benzinga
Australia's Psychedelics Therapy Provides Hope For Treatment-Resistant Mental Health Conditions
February 07, 2023
Tickers
NUMIF
From Benzinga
Psyched: Australia Legalizes Psychedelics Therapy, BC's Decrim, State Bills, Millions For Trials & Clinics
February 06, 2023
From Benzinga
MDMA News: Optimi's New Drug Now Available, Revive Advances Transdermal Patch Evaluations
February 06, 2023
From Benzinga
MDMA Therapy For Chronic PTSD: Neuroimaging With Veterans & First Responders Provides Further Evidence
January 23, 2023
From Benzinga
Psyched: NY Discusses Regulations, MDMA For PTSD Aims For Legalization, Shrooms For Eating Disorders & More
January 10, 2023
From Benzinga
Is Psychedelic Treatment Around The Corner? MDMA For PTSD Checks Positive In MAPS' 2nd Phase 3 Trial
January 05, 2023
From Benzinga
Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More
November 21, 2022
From Benzinga
MAPS Completes Second Phase 3 Trial Of MDMA-Assisted Therapy For PTSD, Topline Data & New Drug Application Next
November 17, 2022
From Benzinga
Atai's New MDMA-Based EMP-01 Compound Moves Forward To The Clinical Stage
September 27, 2022
Tickers
ATAI
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.